[go: up one dir, main page]

NO973908L - Nye selektive inhibitorer av virus- eller bakterie-neuraminidaser - Google Patents

Nye selektive inhibitorer av virus- eller bakterie-neuraminidaser

Info

Publication number
NO973908L
NO973908L NO973908A NO973908A NO973908L NO 973908 L NO973908 L NO 973908L NO 973908 A NO973908 A NO 973908A NO 973908 A NO973908 A NO 973908A NO 973908 L NO973908 L NO 973908L
Authority
NO
Norway
Prior art keywords
viral
selective inhibitors
neuraminidase
compounds
novel selective
Prior art date
Application number
NO973908A
Other languages
English (en)
Other versions
NO973908D0 (no
NO318455B1 (no
Inventor
Norbert W Bischofberger
Choung U Kim
Willard Lew
Hongtao Liu
Matthew A Williams
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27410155&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO973908(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/476,946 external-priority patent/US5866601A/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of NO973908D0 publication Critical patent/NO973908D0/no
Publication of NO973908L publication Critical patent/NO973908L/no
Publication of NO318455B1 publication Critical patent/NO318455B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19973908A 1995-02-27 1997-08-26 Nye forbindelser med inhibitorfunksjon overfor spesielt virus- og bakterieneuraminidaser, farmasoytiske preparater inneholdende forbindelsene, og anvendelser av forbindelsene for a inhibere aktiviteten av spesielt neuraminidaser. NO318455B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US39524595A 1995-02-27 1995-02-27
US08/476,946 US5866601A (en) 1995-02-27 1995-06-06 Carbocyclic compounds
US58056795A 1995-12-29 1995-12-29
PCT/US1996/002882 WO1996026933A1 (en) 1995-02-27 1996-02-26 Novel selective inhibitors of viral or bacterial neuraminidases

Publications (3)

Publication Number Publication Date
NO973908D0 NO973908D0 (no) 1997-08-26
NO973908L true NO973908L (no) 1997-10-27
NO318455B1 NO318455B1 (no) 2005-03-21

Family

ID=27410155

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973908A NO318455B1 (no) 1995-02-27 1997-08-26 Nye forbindelser med inhibitorfunksjon overfor spesielt virus- og bakterieneuraminidaser, farmasoytiske preparater inneholdende forbindelsene, og anvendelser av forbindelsene for a inhibere aktiviteten av spesielt neuraminidaser.

Country Status (26)

Country Link
US (3) US5952375A (no)
EP (1) EP0759917B1 (no)
JP (3) JP3300365B2 (no)
KR (1) KR100447096B1 (no)
CN (2) CN100409844C (no)
AT (2) ATE191711T1 (no)
AU (1) AU720933B2 (no)
BR (2) BR9607098B8 (no)
CZ (1) CZ297945B6 (no)
DE (4) DE759917T1 (no)
DK (1) DK0759917T3 (no)
ES (2) ES2118674T3 (no)
GR (1) GR3033914T3 (no)
HU (1) HU228450B1 (no)
LU (1) LU90991I2 (no)
MX (1) MX9706496A (no)
NL (1) NL300105I2 (no)
NO (1) NO318455B1 (no)
NZ (1) NZ306625A (no)
PL (1) PL194173B1 (no)
PT (1) PT759917E (no)
RU (1) RU2181357C2 (no)
SG (1) SG45864A1 (no)
SI (1) SI9620042A (no)
UA (1) UA56128C2 (no)
WO (1) WO1996026933A1 (no)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3300365B2 (ja) 1995-02-27 2002-07-08 ギリアード サイエンシーズ，インコーポレイテッド ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
US5714509A (en) * 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
US6093816A (en) 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
ES2173480T3 (es) * 1996-08-23 2002-10-16 Gilead Sciences Inc Preparacion de derivados de ciclohexeno carboxilato.
US5859284A (en) * 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
CN1238762A (zh) * 1996-10-21 1999-12-15 吉里德科学公司 哌啶化合物
US5994377A (en) 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
EP0951480A4 (en) * 1996-11-14 2004-07-28 Biota Scient Management METHOD AND NEW CONNECTIONS THAT CAN BE USED IN THIS METHOD.
AU8673598A (en) * 1997-08-01 1999-02-22 University Of Florida Neuraminidase inhibitors
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US20040053999A1 (en) * 1997-09-17 2004-03-18 Bischofberger Norbert W. Novel compounds and methods for synthesis and therapy
CN1272105A (zh) * 1997-09-17 2000-11-01 吉里德科学公司 含六元环的化合物,其制备方法及其作为药物的用途
TW477783B (en) * 1997-12-12 2002-03-01 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
AR016162A1 (es) * 1997-12-17 2001-06-20 Biocryst Pharm Inc Compuestos ciclopentano y ciclopenteno sustituidos que son de utilidad como inhibidores de la neuraminidasa y composicion que los contiene.
US6518305B1 (en) 1998-04-23 2003-02-11 Abbott Laboratories Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
PL343678A1 (en) * 1998-04-23 2001-08-27 Abbott Lab Pyrrolidines as inhibitors of neuraminidases
ES2167975T3 (es) * 1998-05-13 2002-05-16 Hoffmann La Roche Procedimiento para la preparacion de acido shikimico y sus derivados.
AU1476900A (en) * 1998-11-13 2000-06-05 Gilead Sciences, Inc. 1,4,5,6-tetrahydro-pyridazine derivatives, their preparation and their use as neuraminidase inhibitors
AUPP913999A0 (en) * 1999-03-12 1999-04-01 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
DK1059283T3 (da) * 1999-06-11 2003-09-15 Hoffmann La Roche Fremgangsmåde til fremstilling af neuraminidase-inhibitor ro-64-0796
DE19930177B4 (de) 1999-06-30 2007-02-08 Nikolai Vladimirovich Bovin Intermolekular assoziierende Verbindungen und deren Verwendung
US6593314B1 (en) * 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
WO2001028981A1 (en) * 1999-10-19 2001-04-26 Abbott Laboratories 1-cyclohexene-1-carboxylic acid and 1-cyclohexene-1-carboxylates as neuraminidase inhibitors
US6627396B1 (en) * 1999-10-28 2003-09-30 The Regents Of The University Of California Influenza sensor
JP2001131144A (ja) * 1999-11-02 2001-05-15 Sagami Chem Res Center ７−アザビシクロ［４．１．０］ヘプト−３−エン−３−カルボン酸エステル類の製造方法
US6462226B1 (en) * 1999-12-03 2002-10-08 Hoffmann-La Roche Inc. Process for the preparation of 4,5-diamino shikimic acid derivatives
AU1552701A (en) * 1999-12-27 2001-07-09 Kuraray Co., Ltd. Process for the production of 5-oxy-7-oxabicyclo-(4.1.0)hept-3-E NE-3-carboxylic acid esters
US8642051B2 (en) * 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
WO2001080892A1 (en) * 2000-04-25 2001-11-01 Sankyo Company, Limited Preventives for influenza
GB0015324D0 (en) * 2000-06-22 2000-08-16 Biota Scient Management Medicaments
JP4149803B2 (ja) 2000-06-27 2008-09-17 エフ．ホフマン−ラ ロシュ アーゲー 組成物の調製方法
AUPR001000A0 (en) 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
WO2002092555A1 (en) * 2001-05-11 2002-11-21 Sankyo Company, Limited Sialic acid derivatives
US6964784B2 (en) * 2002-03-07 2005-11-15 Optigenex, Inc. Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals
RU2220739C1 (ru) * 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Интраназальное средство
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
US7122684B2 (en) 2003-03-13 2006-10-17 Roche Colorado Corporation Process for preparing 1,2-diamino compounds
JP5280631B2 (ja) 2003-06-16 2013-09-04 インスティチュート オブ オーガニック ケミストリー アンド バイオケミストリー， アカデミー オブ サイエンシズ オブ ザ チェコ リパブリック 抗ウイルスヌクレオチド類似物としてのホスホネート基を有するピリミジン化合物
WO2007053792A2 (en) * 2005-11-05 2007-05-10 Amplyx Pharmaceuticals, Inc. Improving the pharmacokinetics of protease inhibitors and other drugs
ES2366704T3 (es) 2005-11-25 2011-10-24 Hetero Drugs Limited Procedimiento mejorado para fosfato de oseltamivir.
KR100819759B1 (ko) 2005-12-01 2008-04-07 (주)파인켐 아자이드 화합물의 폭발성을 제거한 공정을 이용한 1,2-다이아미노 화합물 또는 이의 부가염 제조 방법
KR20080085061A (ko) * 2005-12-28 2008-09-22 에프. 호프만-라 로슈 아게 타미플루 합성에서의 에폭사이드 중간체
CN101389323B (zh) 2006-02-20 2013-08-21 中外制药株式会社 含有磷酸奥塞米韦的药物组合物
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080306098A1 (en) * 2006-11-06 2008-12-11 Mutz Mitchell W Pharmacokinetics of protease inhibitors and other drugs
AU2008208865B2 (en) 2007-01-23 2013-01-24 Therapicon Srl Antiviral compounds
US20080194801A1 (en) * 2007-02-14 2008-08-14 Swanson Basil I Robust multidentate ligands for diagnosis and anti-viral drugs for influenza and related viruses
US8435769B2 (en) 2007-04-13 2013-05-07 Monsanto Technology Llc Use of glyphosate to produce shikimic acid in microorganisms
US20090054334A1 (en) * 2007-05-23 2009-02-26 Mutz Mitchell W Combinatorial improvement of bifunctional drug properties
CA2697837C (en) * 2007-08-31 2016-08-16 Academia Sinica Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
BRPI0818236B1 (pt) 2007-10-16 2020-07-21 Monsanto Technology Llc processo para recuperação do ácido chiquímico de um fluxo de processo aquoso compreendendo ainda glifosato
WO2009055042A1 (en) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Enhancing the efficacy of anti-infective therapeutics
US8304553B2 (en) * 2007-12-19 2012-11-06 Nanyang Technological University Method of forming oseltamivir and derivatives thereof
US8334319B2 (en) * 2008-01-04 2012-12-18 Roche Palo Alto Llc Polymorphic forms of oseltamivir phosphate
US20100081713A1 (en) * 2008-03-19 2010-04-01 CombinatoRx, (Singapore) Pte. Ltd. Compositions and methods for treating viral infections
US20120058937A9 (en) 2008-04-15 2012-03-08 Tsrl, Inc. Prodrugs of Neuraminidase Inhibitors
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
CN101486664B (zh) * 2008-12-31 2013-09-04 北京大学深圳研究生院 用作流感病毒神经氨酸酶抑制剂的多取代五元环小分子化合物
KR20120025519A (ko) 2009-05-15 2012-03-15 레드엑스 파마 리미티드 산화환원 약물 유도체
WO2011021223A2 (en) * 2009-08-19 2011-02-24 Msn Laboratories Limited Novel salts of ethyl (3r, 4s, 5r)-4,5-imino-3-(l-ethylpropoxy)-1- cvclohexene-1-carboxylate and its use
WO2011059994A2 (en) * 2009-11-11 2011-05-19 3M Innovative Properties Company Polymeric compositions and method of making and articles thereof
IT1396620B1 (it) 2009-11-25 2012-12-14 Therapicon Srl Analoghi chimerici
EP2593430A1 (en) 2010-07-16 2013-05-22 Grindeks Derivatives of 1,4-dihydropyridine possessing antiviral efficacy
AT510585B1 (de) 2010-11-18 2012-05-15 Apeptico Forschung & Entwicklung Gmbh Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
EP2578218A1 (en) 2011-10-06 2013-04-10 Grindeks, A Joint Stock Company Antiviral efficacy of disodium 2,6-dimethyl-1,4-dihydropyridine-3,5-bis(carbonyloxyacetate) and its derivatives
DE102011117128A1 (de) 2011-10-28 2013-05-02 Christian-Albrechts-Universität Zu Kiel Verbindungen zur Therapie der Influenza
RU2469020C1 (ru) * 2011-11-08 2012-12-10 Александр Васильевич Иващенко (3r,4r,5s)-5-амино-4-ациламино-3-(1-этил-пропокси)-циклогекс-1-ен-карбоновые кислоты, их эфиры и способ применения
RU2489422C1 (ru) * 2012-05-12 2013-08-10 Александр Васильевич Иващенко Фторзамещенные (3r,4r,5s)-5-гуанидино-4-ациламино-3-(пентан-3-илокси)циклогексен-1-карбоновые кислоты, их эфиры и способ применения
RU2521593C1 (ru) * 2013-02-27 2014-06-27 Общество с ограниченной ответственностью "Интеллектуальный Диалог" Моно и дифторзамещенные этил (3r,4r,5s)-5-азидо-4-ацетиламино-3-(1-этилпропокси)-циклогексен-1-карбоксилаты, способ получения и применения
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 ２−デオキシ−２，３−ジデヒドロシアル酸誘導体およびその製造法
CN103819357B (zh) * 2014-01-28 2016-03-16 浙江大学 (-)-有效霉醇叠氮四乙酸酯的制备方法
EP3351528A1 (en) 2014-02-14 2018-07-25 TOA Eiyo Ltd. Cyclic hydrocarbon compound
AU2015260841A1 (en) 2014-05-12 2016-12-01 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions comprising danirixin for treating infectious diseases
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
GB2532178A (en) * 2014-06-09 2016-05-18 Redx Pharma Plc Antiviral compounds
SG11201705069YA (en) 2014-12-26 2017-07-28 Univ Emory N4-hydroxycytidine and derivatives and anti-viral uses related thereto
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
US10676428B2 (en) 2015-12-17 2020-06-09 Ramot At Tel-Aviv University Ltd. Antiviral agents for amantadine-resistant influenza A
KR102339817B1 (ko) 2016-06-30 2021-12-16 한미약품 주식회사 오셀타미비어 함유 경구용 고형제제 및 그 제조방법
SG11201900869QA (en) * 2016-08-10 2019-02-27 Shionogi & Co Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof
WO2019113462A1 (en) 2017-12-07 2019-06-13 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
KR20200106607A (ko) 2019-03-05 2020-09-15 주식회사 코아팜바이오 오셀타미비르 함유 의약 조성물

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
US5206400A (en) * 1986-07-07 1993-04-27 Ohio State University Diastereomeric mono- and di-substituted diamino cyclohexane compounds and the method of preparation thereof
EP0398924B1 (en) * 1988-01-12 1996-06-26 Board Of Regents, The University Of Texas System Histamine release inhibitory factor and preparations therefore
US5175273A (en) * 1988-07-01 1992-12-29 Genentech, Inc. Nucleic acid intercalating agents
US5270340A (en) * 1988-12-27 1993-12-14 Bayer Aktiengesellschaft Substituted 2-cyclohexen-1-yl-amine fungicidal and herbicidal agents
GB2238049A (en) * 1989-11-22 1991-05-22 Ki Nii Epidemiologii I Infekts Method for preparing inhibitor for influenza virus neuraminidase
CZ288492B6 (en) * 1990-04-24 2001-06-13 Biota Scient Management Derivatives of alpha-D-neuraminic acid, process of their preparation, their use and pharmaceutical preparations based thereon
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
DE4033415A1 (de) * 1990-10-20 1992-04-23 Bayer Ag Antimikrobielle mittel sowie substituierte 2-cyclohexan-1-yl-amin-derivate und deren herstellung
DE4131311A1 (de) * 1991-09-20 1993-04-01 Basf Ag Dihydropyranderivate und diese enthaltende pflanzenschutzmittel
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5292938A (en) * 1992-04-13 1994-03-08 Associated Universities, Inc. Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging
US5633360A (en) 1992-04-14 1997-05-27 Gilead Sciences, Inc. Oligonucleotide analogs capable of passive cell membrane permeation
GB9220327D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
GB9220241D0 (en) * 1992-09-25 1992-11-11 Glaxo Group Ltd Process
US5639786A (en) * 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
US5514798A (en) * 1993-06-02 1996-05-07 Gilead Sciences, Inc. Method and cyclic carbonates for nucleotide analogues
GB9311873D0 (en) * 1993-06-09 1993-07-28 Glaxo Group Ltd Process
GB9311892D0 (en) * 1993-06-09 1993-07-28 Glaxo Wellcome Australia Ltd Device
GB9312531D0 (en) * 1993-06-17 1993-08-04 Glaxo Group Ltd Process
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
GB9400206D0 (en) * 1994-01-07 1994-03-02 Glaxo Group Ltd Chemical compound
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
GB9410817D0 (en) * 1994-05-28 1994-07-20 Glaxo Group Ltd Medicaments
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds
US5556963A (en) * 1994-08-05 1996-09-17 Oklahoma Medical Research Foundation Synthesis of 4-alkoxy-N-acetylneuraminic acid
GB9416365D0 (en) * 1994-08-12 1994-10-05 Glaxo Group Ltd Medicaments
US5512596A (en) * 1994-09-02 1996-04-30 Gilead Sciences, Inc. Aromatic compounds
JP2002515849A (ja) 1994-11-04 2002-05-28 ギリアード サイエンシーズ，インコーポレイテッド Ｈｉｖプロテアーゼを阻害および検出するチエパン化合物
JP3300365B2 (ja) * 1995-02-27 2002-07-08 ギリアード サイエンシーズ，インコーポレイテッド ウイルスまたは細菌ノイラミニダーゼの新規な選択的インヒビター
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5602277A (en) * 1995-03-30 1997-02-11 Biocryst Pharmaceuticals, Inc. Substituted benzene derivatives useful as neuraminidase inhibitors
US5714509A (en) 1995-05-03 1998-02-03 The University Of Alabama Inhibitors of bacterial sialidase and methods of making and using the same
GB9525389D0 (en) 1995-12-12 1996-02-14 Biota Scient Management Ltd Chemical compounds
GB9510141D0 (en) 1995-05-19 1995-07-12 Biota Scient Management Chemical compounds
KR19990014910A (ko) * 1995-05-19 1999-02-25 리차드 에이. 웨이들리 6-카르복사미도 디히드로피란 유도체
GB9516276D0 (en) 1995-08-08 1995-10-11 Biota Scient Management Chemical compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
ES2173480T3 (es) 1996-08-23 2002-10-16 Gilead Sciences Inc Preparacion de derivados de ciclohexeno carboxilato.
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US5948816A (en) * 1996-09-10 1999-09-07 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
US5886213A (en) 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds

Also Published As

Publication number Publication date
EP0759917A1 (en) 1997-03-05
DE69635231D1 (de) 2006-02-09
DE69607704T2 (de) 2000-12-28
NL300105I2 (nl) 2003-02-03
SI9620042A (sl) 1998-12-31
AU720933B2 (en) 2000-06-15
HK1026893A1 (en) 2000-12-29
AU5357196A (en) 1996-09-18
HUP9800026A3 (en) 2002-04-29
NO973908D0 (no) 1997-08-26
BR9607098B8 (pt) 2014-11-18
RU2181357C2 (ru) 2002-04-20
EP0759917B1 (en) 2000-04-12
UA56128C2 (uk) 2003-05-15
ES2249863T3 (es) 2006-04-01
ATE191711T1 (de) 2000-04-15
JPH11501908A (ja) 1999-02-16
DE759917T1 (de) 1998-10-22
DE69607704D1 (de) 2000-05-18
PT759917E (pt) 2000-10-31
MX9706496A (es) 1997-11-29
PL194173B1 (pl) 2007-05-31
NO318455B1 (no) 2005-03-21
PL322000A1 (en) 1998-01-05
GR3033914T3 (en) 2000-11-30
HU228450B1 (en) 2013-03-28
ES2118674T1 (es) 1998-10-01
KR19980703600A (ko) 1998-12-05
LU90991I2 (fr) 2003-02-11
DE10299052I1 (de) 2003-05-22
DE69635231T2 (de) 2006-07-13
CN1347693A (zh) 2002-05-08
JP3300365B2 (ja) 2002-07-08
DK0759917T3 (da) 2000-07-31
US20050176758A1 (en) 2005-08-11
BR9607098A (pt) 1997-11-04
WO1996026933A1 (en) 1996-09-06
CZ297945B6 (cs) 2007-05-02
NZ306625A (en) 2001-04-27
CZ269097A3 (en) 1997-11-12
CN100409844C (zh) 2008-08-13
JP2006036770A (ja) 2006-02-09
HUP9800026A2 (hu) 1999-09-28
SG45864A1 (en) 1999-04-27
US5952375A (en) 1999-09-14
KR100447096B1 (ko) 2005-10-11
ES2118674T3 (es) 2000-08-16
ATE305453T1 (de) 2005-10-15
JP4234917B2 (ja) 2009-03-04
JP2002161074A (ja) 2002-06-04
US6225341B1 (en) 2001-05-01
NL300105I1 (nl) 2003-01-06
CN1147813A (zh) 1997-04-16
CN1185223C (zh) 2005-01-19

Similar Documents

Publication Publication Date Title
NO973908D0 (no) Nye selektive inhibitorer av virus- eller bakterie-neuraminidaser
TR200000723T2 (tr) Altı elemanlı halkalar ihtiva eden bileşikler ve ilaç olarak kullanımları.
PT922226E (pt) Processo para a avaliacao do estado de um organismo por meio de medicao de peptideos
PT788605E (pt) Deteccao de anticorpos bacterianos por polarizacao de fluorescencia
EP0980524A4 (en) DETERMINATION OF MOLECULAR INTERACTIONS THROUGH MARKER UNIT COMPLEMENTATION
BR9812783A (pt) "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas"
WO1997011690A3 (en) Inhibitors of regulatory pathways
ATE320819T1 (de) Bestimmung von antigenen mittels oligonukleotid- antikörper-konjugaten
DE69911062D1 (de) Verfahren und material zum selektiven nachweis von toxinen
BR9811039A (pt) Citocina de mamìferos: interleucina-b30 e reagentes relacionados
EP0976734A3 (en) Selective inhibitors of viral or bacterial neuraminidase
CY1108288T1 (el) Αντισωματα για το αντιγονο κυτταρων langerhans θηλαστικων και χρησεις τους
FR2774097B1 (fr) Utilisation de derives d'indolamine dans la detection d'une activite de peptidase ou dans la detection de micro-organismes
ATE389881T1 (de) Detektion von kleinen molekülen mit piezo- elektrischem sensor
DE69431802D1 (de) Detektierung und artbestimmung von campylobacter
FR2799281B1 (fr) Procede et dispositif de detection d'une reaction de reconnaissance moleculaire
FR2728904B1 (fr) Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
WO1999010365A3 (en) 5',5'-linked oligomers having anti-thrombin activity
ATE158815T1 (de) Hippurikasegen
FR2700864B1 (fr) Système détecteur de falsification d'informations mémorisées.
KR950020303U (ko) 환형 세선 파단시편 단면적 측정지그
ITCN960010A1 (it) Sistema di vibrola per chitarra e strumenti simili.
IT1298510B1 (it) Sistema di consenso all'attivazione di bilance che memorizzano varie pesate e conteggi effettuati da uno di vari operatori,abilitate
IT1219864B (it) Procedimento per la biodegrazione di materiali organici contenenti lignia mediante microorganismi e impianto per la sua conduzione

Legal Events

Date Code Title Description
MK1K Patent expired